Evidence map›Paper›PMID 38367138›Full record

ArticleDrug safety2024

Correction to: Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative.

Eric B Cohen, Meenal Patwardhan, Ritu Raheja, David H Alpers, Raul J Andrade, Mark I Avigan, James H Lewis, Don C Rockey, Francis Chui, Alexandru M Iacob and 4 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Drug safety, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 9 institutions in 2 countries.

Eric B CohenPharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA. eric.cohen@abbvie.com.
Meenal PatwardhanPharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA.
Ritu RahejaPharmacovigilance and Patient Safety, AbbVie Inc., North Chicago, IL, USA.
David H AlpersDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Raul J AndradeDepartment of Medicine, IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain.
Mark I AviganFood and Drug Administration, Center for Drug Evaluation and Research, Silver Spring, MD, USA.
James H LewisDivision of Gastroenterology, Georgetown University, Washington, D.C., USA.
Don C RockeyDigestive Disease Research Center, Medical University of South Carolina, Charleston, SC, USA.
Francis ChuiPharmacovigilance, Gilead Sciences Inc., Foster City, CA, USA.
Alexandru M IacobPharmacovigilance and Patient Safety, AbbVie Inc., Ottawa, ON, Canada.
Camila C LinardiTranslational Medicine, Bayer HealthCare Pharmaceuticals LLC, Whippany, NJ, USA.
Arie RegevGlobal Patient Safety, Eli Lilly and Company, Indianapolis, IN, USA.
Jesse ShickPharmacovigilance, Gilead Sciences Inc., Foster City, CA, USA.
M Isabel LucenaDepartment of Pharmacology and Pediatrics, IBIMA_Plataforma Bionand, University of Malaga, Malaga, Spain.
AbbVie (United States) · USGilead Sciences (United States) · USInstituto de Investigación Biomédica de Málaga · ESBayer (United States) · USCenter for Drug Evaluation and Research · USEli Lilly (United States) · USGeorgetown University · USMedical University of South Carolina · USWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38367138
PMCPMC11018680
OpenAlexW4391915236

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.